Loading...
XHKG
1558
Market cap1.76bUSD
Jun 16, Last price  
14.76HKD
1D
2.64%
1Q
48.79%
Jan 2017
90.45%
IPO
101.64%
Name

Yichang Hec Changjiang Pharmactcl Co Ltd

Chart & Performance

D1W1MN
No data to show
P/E
26.11
P/S
3.39
EPS
0.52
Div Yield, %
—
Shrs. gr., 5y
-2.71%
Rev. gr., 5y
-9.76%
Revenues
3.72b
-40.84%
316,429,000440,904,000692,910,000941,504,0001,601,567,0002,510,476,0006,224,024,0002,348,113,000913,788,0003,744,952,0006,294,585,0003,723,783,000
Net income
483m
-75.78%
57,800,000135,343,000265,750,000380,597,000647,101,000942,536,0001,918,709,000839,455,000-587,649,00076,603,0001,992,624,000482,712,000
CFO
0k
-100.00%
51,546,000129,877,999287,394,000397,206,000670,751,000715,392,0001,794,407,0001,299,493,000-662,510,0001,699,909,0001,673,212,0000
Dividend
Sep 29, 20200.1136 HKD/sh
Earnings
Aug 28, 2025

Profile

YiChang HEC ChangJiang Pharmaceutical Co., Ltd. develops, manufactures, and sells pharmaceutical products in the therapeutic areas of anti-virus, endocrine and metabolic diseases, and cardiovascular diseases in the People's Republic of China. It also manufactures and sells active pharmaceutical ingredients; researches and develops medical devices and drugs, as well as biotechnology; and provides medical consulting services. The company sells its products to hospitals and medical institutions through a network of distributors. It has a strategic cooperation framework agreement with Alibaba Health Technology (China) Limited to carry out influenza special projects; Jointown Pharmaceutical Group Co., Ltd.; Guangdong Yihao Pharmaceutical Co., Ltd.; and Shenzhen HEC Industrial Development Co., Ltd, as well as strategic cooperative partnership with China National Accord Medicines Corporation Ltd. The company was formerly known as Yichang Changjiang Pharmaceutical Company Limited and changed its name to YiChang HEC ChangJiang Pharmaceutical Co., Ltd. in May 2015. The company was incorporated in 2001 and is based in Yichang, China. YiChang HEC ChangJiang Pharmaceutical Co., Ltd. is a subsidiary of Guangdong HEC Technology Holding Co., Ltd.
URL
http://www.hec-changjiang.com/
IPO date
Dec 29, 2015
Employees
4,499
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
3,723,783
-40.84%
6,294,585
68.08%
3,744,952
309.83%
Cost of revenue
2,962,536
3,433,960
2,583,534
Unusual Expense (Income)
NOPBT
761,247
2,860,625
1,161,418
NOPBT Margin
20.44%
45.45%
31.01%
Operating Taxes
94,521
270,945
9,817
Tax Rate
12.42%
9.47%
0.85%
NOPAT
666,726
2,589,680
1,151,601
Net income
482,712
-75.78%
1,992,624
2,501.23%
76,603
-113.04%
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
1,335,029
2,319,877
3,130,306
Long-term debt
1,213,670
290,975
829,471
Deferred revenue
187,145
187,489
Other long-term liabilities
180,682
(691,529)
Net debt
1,098,553
885,595
(2,414,305)
Cash flow
Cash from operating activities
1,673,212
1,699,909
CAPEX
(343,718)
(570,070)
Cash from investing activities
554,568
(1,120,161)
Cash from financing activities
(1,476,899)
(787,027)
FCF
968,251
2,003,066
(1,430,611)
Balance
Cash
1,407,616
1,693,099
1,213,543
Long term investments
42,530
32,158
5,160,539
Excess cash
1,263,957
1,410,528
6,186,834
Stockholders' equity
8,508,196
8,375,500
6,070,001
Invested Capital
9,659,756
9,321,458
3,344,686
ROIC
7.03%
40.89%
35.09%
ROCE
6.97%
26.66%
11.71%
EV
Common stock shares outstanding
879,968
879,968
879,968
Price
9.56
0.74%
9.49
46.00%
6.50
6.56%
Market cap
8,412,491
0.74%
8,350,893
46.00%
5,719,790
6.56%
EV
9,511,044
9,676,475
3,490,602
EBITDA
761,247
3,251,899
1,538,775
EV/EBITDA
12.49
2.98
2.27
Interest
227,398
281,646
Interest/NOPBT
7.95%
24.25%